YourHealthRx review

YourHealthRx’s current public semaglutide page lists $170 for the monthly injection option and its tirzepatide page lists $210. Both explicitly say billed monthly, with the same price regardless of the prescribed dose. Clinical access, coordination and a prescription when issued are bundled; the homepage says no separate standard shipping or clinician-review fee unless noted. That is a published offer, not a guarantee of a prescription or an unchanging future price. The lowest homepage headline requires a six-month prepayment rather than the flexible monthly bill. The cost guide explains how to compare a flexible monthly quote with a larger commitment.

The three- and six-month product options show a lower monthly equivalent but explicitly require one upfront payment. The medication pages explain that distinction before routing applicants to the clinical partner. Do not treat the lowest headline as a month-to-month bill or assume unused prepaid medicine is refundable. Ask for the next renewal date, whether a long plan renews automatically, and the remedies if the clinician changes or stops treatment. Prices are expressly subject to change. The published program price covers access and coordination as well as a prescription if issued, so a medical decision against treatment does not necessarily unwind every service charge. That difference matters before submitting an intake.

Both compounds are offered as oral dissolving tablets as well as injections. The current tablet monthly prices are $200 and $220; the tirzepatide injection is described as including cyanocobalamin, or vitamin B12. These are compounded preparations, not an FDA-approved Wegovy tablet or an approved oral tirzepatide brand. A shared ingredient name or convenient route does not establish equivalent absorption, dosing or clinical results. The oral semaglutide guide explains formulation differences, and the tirzepatide evidence review separates branded trial results from a particular compounded product. An individualized clinical need and applicable compounding conditions still need to be assessed by the prescriber.

YourHealth describes YourHealthRx as an access, education and marketing platform, not a medical practice or pharmacy. Its privacy statement identifies Ola Digital Health as its contracted clinical-platform partner, with clinical data handled through partner workflows. The public routing form is described as collecting basic routing information, not medical history or laboratory records; use the clinical partner’s proper intake for sensitive health details. Availability pages describe physicians, nurse practitioners and physician assistants in the network, but do not name the assigned clinician or dispensing pharmacy. Statements about state licenses, USP standards, source ingredients or lot certificates are provider representations, not independent license or product-quality verification. Ask for the exact prescriber and dispensing location and how to contact them about symptoms or product questions.

The current availability page advertises consultations in all 50 states and says pharmacy fulfillment excludes DC, with additional California exclusions for a named set of injectables. Its per-product table places semaglutide and tirzepatide cold-chain injections in the 50-state category; confirm the exact formulation and current shipping eligibility. The clinical partner determines whether a live or asynchronous consultation applies to the case and state. It estimates shipping at three to seven business days and describes ongoing follow-up, lab review and adjustments without a guaranteed visit frequency. For refunds, administrative onboarding or access provisioning can make coordination fees generally nonrefundable before a clinician has reviewed anything. Duplicate or erroneous billing, unresolved technical access problems and legally required remedies have separate consideration within thirty days. Clinical-provider and pharmacy refund rules are separate again; ask who retains each charge rather than infer a universal no-refund or full medical-denial guarantee.